Neuronal circuits, neurophysiology and optogenetic approaches, Novel methods and technology in neuroscience

Publication date: 23/12/2025

Authors: Aggarwal A, Negrean A, Chen Y, Iyer R, Reep D, Liu A, Palutla A, Xie ME, MacLennan BJ, Hagihara KM, Kinsey LW, Sun JL, Yao P, Zheng J, Tsang A, Tsegaye G, Zhang Y, Patel RH, Arthur BJ, Hiblot J, Leipp

Journal: Nature Methods

Commentary: In this study, Aggarwal et al. developed two fourth-generation glutamate indicators, iGluSnFR4f and iGluSnFR4s, that considerably advance the sensitivity and kinetic tunability of genetically encoded glutamate sensors. The central innovation lies in overcoming a long-standing bottleneck in systems neuroscience: the difficulty of recording synaptic inputs in vivo with sufficient sensitivity and temporal precision. While calcium imaging has enabled large-scale monitoring of neuronal output, direct measurement of incoming glutamatergic signals has remained limited. iGluSnFR4 variants bridge this gap. iGluSnFR4f enables precise tracking of rapid synaptic dynamics, whereas iGluSnFR4s provides higher affinity and markedly improved signal-to-noise ratio. Importantly, both variants detect single-vesicle release in vivo. Beyond technical improvement, the conceptual impact is considerable. These sensors allow direct observation of how neurons integrate thousands of glutamatergic inputs to generate electrical output—the fundamental computation underlying learning, memory and emotion. This capability opens new avenues for dissecting synaptic integration, dendritic processing and circuit-level dysfunction. Given the central role of glutamate dysregulation in disorders such as Alzheimer’s disease, autism spectrum disorders, schizophrenia and epilepsy, iGluSnFR4 can provide a powerful platform for mechanistic studies and for testing how candidate therapeutics modulate synaptic communication in intact neural circuits.

Commented by: Uguagliati Beatrice

DOI: 10.1038/s41592-025-02965-z